Black tea extract and theaflavin derivatives affect the pharmacokinetics of rosuvastatin by modulating organic anion transporting polypeptide (OATP) 2B1 activity
Biopharmaceutics & Drug Disposition · 2019-09 · 40 (8) · 302-306
DOI: 10.1002/bdd.2202 ↗At a glance
Journal article in Biopharmaceutics & Drug Disposition, published online on 2019-10-02. Written by Ayuko Kondo and 6 co-authors. Institution: Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo,…. Cited 14 times so far (Crossref); 27 references. Funded by: Japan Society for the Promotion of Science/JSPS KAKENHI, Japan Society for the Promotion of Science.
Abstract (original language)
Theaflavins (TFs) are derived from black tea, an important source of dietary polyphenols. Although the potential interactions between dietary polyphenols and drugs have been demonstrated through in vitro and in vivo studies, little information is available concerning the influence of TFs on drug disposition. Organic anion transporting polypeptide 2B1 (OATP2B1) is expressed in human enterocytes and plays a role in the intestinal absorption of numerous drugs. The current study evaluated the effects of black tea extracts on the pharmacokinetics of rosuvastatin in rats, and investigated the effect of four major TFs (theaflavin, theaflavin‐3‐gallate, theaflavin‐3′‐gallate and theaflavin‐3,3′‐digallate) on the transport activity of OATP2B1. Black tea extracts significantly decreased the maximum plasma concentration (C max ) and area under the plasma concentration–time curve (AUC 0 – 8 ) of rosuvastatin by 48% and 37%, respectively (p < 0.001 and p < 0.01, respectively). Moreover, OATP2B1‐mediated rosuvastatin and estrone‐3‐sulfate uptake was significantly reduced in the presence of TFs. A kinetic study revealed that the uptake efficiency (in terms of V max /K m ) of rosuvastatin was decreased following treatment with TFs. Black tea extracts also reduced OATP2B1‐mediated rosuvastatin uptake. These results suggest that black tea reduces the plasma concentrations of rosuvastatin by inhibiting the intestinal OATP2B1‐mediated transport of rosuvastatin.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo, 060-0812, Japan.
- Department of Pharmacy, Hokkaido University Hospital, Kita-14-jo, Nishi-5-chome, Kita-ku, Sapporo, 060-8648, Japan.
ORCID profiles: Ken Iseki
Funding
- Japan Society for the Promotion of Science/JSPS KAKENHI
- Japan Society for the Promotion of Science
Cite
APA
Kondo, A., Narumi, K., Okuhara, K., Takahashi, Y., Furugen, A., Kobayashi, M., & Iseki, K. (2019). Black tea extract and theaflavin derivatives affect the pharmacokinetics of rosuvastatin by modulating organic anion transporting polypeptide (OATP) 2B1 activity. Biopharmaceutics & Drug Disposition, 40(8), 302-306. https://doi.org/10.1002/bdd.2202
Vancouver
Kondo A, Narumi K, Okuhara K, Takahashi Y, Furugen A, Kobayashi M, et al. Black tea extract and theaflavin derivatives affect the pharmacokinetics of rosuvastatin by modulating organic anion transporting polypeptide (OATP) 2B1 activity. Biopharmaceutics & Drug Disposition. 2019;40(8):302-306. doi:10.1002/bdd.2202
BibTeX
@article{Kondo2019,
author = {Kondo, Ayuko and Narumi, Katsuya and Okuhara, Keisuke and Takahashi, Yuka and Furugen, Ayako and Kobayashi, Masaki and Iseki, Ken},
title = {Black tea extract and theaflavin derivatives affect the pharmacokinetics of rosuvastatin by modulating organic anion transporting polypeptide (OATP) 2B1 activity},
journal = {Biopharmaceutics & Drug Disposition},
year = {2019},
volume = {40},
number = {8},
pages = {302--306},
doi = {10.1002/bdd.2202}
}
EUVIMED